NDC 0407-1412

OMNIPAQUE

Iohexol

OMNIPAQUE is a Intrathecal; Intravascular; Intravenous; Oral Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Ge Healthcare Inc.. The primary component is Iohexol.

Product ID0407-1412_139bf586-5a7e-41fc-8d29-df0c15a326be
NDC0407-1412
Product TypeHuman Prescription Drug
Proprietary NameOMNIPAQUE
Generic NameIohexol
Dosage FormInjection, Solution
Route of AdministrationINTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL
Marketing Start Date2005-08-11
Marketing CategoryNDA / NDA
Application NumberNDA018956
Labeler NameGE Healthcare Inc.
Substance NameIOHEXOL
Active Ingredient Strength240 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0407-1412-38

10 BOTTLE, PLASTIC in 1 BOX (0407-1412-38) > 50 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2005-08-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0407-1412-27 [00407141227]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26

NDC 0407-1412-33 [00407141233]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-90 [00407141290]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26
Marketing End Date2010-10-14

NDC 0407-1412-30 [00407141230]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-32 [00407141232]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26
Marketing End Date2010-10-14

NDC 0407-1412-34 [00407141234]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-91 [00407141291]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26
Marketing End Date2010-10-14

NDC 0407-1412-28 [00407141228]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-60 [00407141260]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-38 [00407141238]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-08-11

NDC 0407-1412-49 [00407141249]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26

NDC 0407-1412-26 [00407141226]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26
Marketing End Date2010-10-14

NDC 0407-1412-35 [00407141235]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-10 [00407141210]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-29 [00407141229]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-39 [00407141239]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-08-11

NDC 0407-1412-20 [00407141220]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-40 [00407141240]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-08-11

NDC 0407-1412-84 [00407141284]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-08-11

NDC 0407-1412-50 [00407141250]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-26

NDC 0407-1412-51 [00407141251]

OMNIPAQUE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018956
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-26
Marketing End Date2009-11-04

Drug Details

Active Ingredients

IngredientStrength
IOHEXOL240 mg/mL

OpenFDA Data

SPL SET ID:eee15ebe-d349-4497-acef-6abe7a8247fb
Manufacturer
UNII

Pharmacological Class

  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]
  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]

NDC Crossover Matching brand name "OMNIPAQUE" or generic name "Iohexol"

NDCBrand NameGeneric Name
0407-1401OMNIPAQUEIohexol
0407-1411OMNIPAQUEIohexol
0407-1412OMNIPAQUEIohexol
0407-1413OmnipaqueIohexol
0407-1414OmnipaqueIohexol
0407-1415OMNIPAQUEOMNIPAQUE
0407-1416OMNIPAQUEOMNIPAQUE

Trademark Results [OMNIPAQUE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OMNIPAQUE
OMNIPAQUE
73340246 1207823 Live/Registered
Sterling Drug Inc.
1981-12-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.